Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2022-11-25 00:00:00 ET · period of report 2022-11-22 · accession 0001062993-22-022779 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-25 | 2022-11-22 | COLL | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale+OE | $22.00 | -65 | 323.5K | -0.0% | -$1,430 |
| D | 2022-11-25 | 2022-11-22 | COLL | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $15.90 | +65 | 323.5K | +0.0% | +$1,034 |
| D | 2022-11-25 | 2022-11-22 | COLL | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $0.00 | -65 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-22 | S | D | 65 | $22.00 | 323,453 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-22 | M | A | 65 | $15.90 | 323,518 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Purchase) | 2022-11-22 | M | D | 65 | $0.00 | 0 | D | $15.90 · — to 2029-01-25 | 65 Common Stock | (F2) All of the 65 option shares are exercisable. |